Loading clinical trials...
Loading clinical trials...
30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children With Various Manifestations of Venous Thrombosis
Conditions
Interventions
Rivaroxaban (Xarelto, BAY59-7939)
Locations
29
United States
Gainesville, Florida, United States
Pensacola, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
Parkville, Victoria, Australia
Start Date
January 15, 2015
Primary Completion Date
April 5, 2017
Completion Date
April 5, 2017
Last Updated
August 21, 2018
NCT06189313
NCT07015905
NCT03728166
NCT07310693
NCT07288632
NCT06451003
Lead Sponsor
Bayer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions